Noura Abul-Husn, M.D., Ph.D.
Department of Genetics and Genomic Sciences, Division of Medical Genetics, Icahn School of Medicine, Mount Sinai, New York, New York
Dana K. Andersen, M.D., F.A.C.S.
Division of Digestive Diseases and Nutrition, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Maryland
David Bernstein, Ph.D.
Stand Up To Cancer, New York, New York
Søren Brunak, Ph.D.
Brunak Group, University of Copenhagen, Copenhagen, Denmark
Marcia (Mimi) Canto, M.D., M.H.S.
Division of Gastroenterology, Johns Hopkins University School of Medicine, Baltimore, Maryland
Suresh Chari, M.D.*
Department of Gastroenterology, Hepatology and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, Texas
Yonina C. Eldar, Ph.D.
Department of Math and Computer Science, Weizmann Institute of Science, Rehovot, Israel
Elliot K. Fishman, M.D.
Department of Radiology and Radiological Science, Johns Hopkins Medicine, Baltimore, Maryland
Julie Fleshman, J.D., M.B.A.
Pancreatic Cancer Action Network, Manhattan Beach, California
Vay Liang W (Bill) Go, M.D.
UCLA Center for Excellence in Pancreatic Diseases, University of California, Los Angeles, Los Angeles, California
Jane M. Holt, B.A.
National Pancreas Foundation, Bethesda, Maryland
William Hoos, M.B.A.
1440 Foundation, Chapel Hill, North Carolina
Christine Iacobuzio-Donahue, M.D., Ph.D.
David M. Rubenstein Center for Pancreatic Cancer Research, Memorial Sloan Kettering Cancer Center, New York, New York
David Kelsen, M.D.§
Edward S. Gordon Chair in Medical Oncology, Memorial Sloan Kettering Cancer Center, New York, New York
Barbara J. Kenner, Ph.D.
Kenner Family Research Fund, New York, New York
David S. Klimstra, M.D.*
Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York
Debiao Li, Ph.D.
Biomedical Research Institute, Cedars-Sinai Medical Center, Los Angeles, California
Graham Lidgard, Ph.D.
Exact Sciences, Madison, Wisconsin
Anirban Maitra, M.B.B.S.
Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas
Lynn M. Matrisian, Ph.D., M.B.A.
Pancreatic Cancer Action Network, Manhattan Beach, California
Stephen Pandol, M.D.‡
Director of the Basic and Translational Pancreas Research Program, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, California
Sung Poblete, R.N., Ph.D.
Stand Up To Cancer, Los Angeles, California
Michael Rosenthal, M.D., Ph.D.§
Department of Radiology, Dana-Farber Cancer Institute, Boston, Massachusetts
Anil K. Rustgi, M.D.‡
Department of Medicine, Division of Digestive & Liver Diseases, NewYork-Presbyterian/Columbia University Irving Medical Center, New York, New York
Chris Sander, Ph.D.
Sander Lab, Dana-Farber Cancer Institute, Boston, Massachusetts
Lawrence H. Schwartz, M.D.
Department of Radiology, NewYork-Presbyterian Hospital/Columbia University Irving Medical Center, New York, New York
Uri Shalit, Ph.D.
Faculty of Industrial Engineering and Management, Technion – Israel Institute of Technology, Haifa, Israel
Sudhir Srivastava, Ph.D., M.P.H., M.S.
Division of Cancer Prevention, National Cancer Institute, Bethesda, Maryland
James A. Taylor, M.D.+
Google Health, Seattle, Washington
Brian Wolpin, M.D., M.P.H.
Gastrointestinal Cancer Center, Dana-Farber Cancer Institute, Boston, Massachusetts
Adam Yala, Ph.D. candidate+
MIT CSAIL, Cambridge, Massachusetts
*Co-leaders, Progress, Problems, and Prospects of Early Detection
+Co-leaders, AI and Machine Learning
§ Co-leaders, AI and Early Detection of Pancreatic Cancer – Current Efforts
‡ Co-leaders, Collaborative Opportunities